Other OTC - Delayed Quote • USD
Ingen Technologies, Inc. (IGNT)
As of April 3 at 3:25 PM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Gary B. Tilden | Chairman of the Board, COO & Secretary | 120k | -- | 1955 |
| Mr. David S. Hanson | CEO & Director | -- | -- | 1946 |
| Mr. Richard O. Weed | General Counsel | -- | -- | 1962 |
Ingen Technologies, Inc.
3410 La Sierra Avenue
Suite F 507
Riverside, CA 92503
United States
- Sector:
- Healthcare
- Industry: Medical Devices
Description
Ingen Technologies, Inc. engages in the research and development of home healthcare products for the respiratory industry in United States. It offers oxygen flow meters and nasal cannulas under the Oxyview and Smart Nasal Cannula trademark names for patients suffering with chronic obstructive pulmonary disease. The company was founded in 1999 and is based in Riverside, California.
Corporate Governance
Ingen Technologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
Upcoming Events Information Not Available